SpringWorks Therapeutics Statistics
Total Valuation
BAFN has a market cap or net worth of $50.89 million. The enterprise value is $36.86 million.
Important Dates
The last earnings date was Tuesday, July 29, 2025, after market close.
Earnings Date | Jul 29, 2025 |
Ex-Dividend Date | May 30, 2025 |
Share Statistics
BAFN has 4.13 million shares outstanding. The number of shares has decreased by -1.02% in one year.
Current Share Class | 4.13M |
Shares Outstanding | 4.13M |
Shares Change (YoY) | -1.02% |
Shares Change (QoQ) | +0.49% |
Owned by Insiders (%) | 14.75% |
Owned by Institutions (%) | 14.29% |
Float | 3.52M |
Valuation Ratios
The trailing PE ratio is 6.86.
PE Ratio | 6.86 |
Forward PE | n/a |
PS Ratio | 0.68 |
Forward PS | n/a |
PB Ratio | 0.58 |
P/TBV Ratio | 0.58 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 4.73 |
EV / Sales | 0.47 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.93%.
Return on Equity (ROE) | 8.93% |
Return on Assets (ROA) | 0.73% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | $261,575 |
Profits Per Employee | $26,087 |
Employee Count | 299 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, BAFN has paid $3.13 million in taxes.
Income Tax | 3.13M |
Effective Tax Rate | 25.10% |
Stock Price Statistics
The stock price has decreased by -2.67% in the last 52 weeks. The beta is 0.04, so BAFN's price volatility has been lower than the market average.
Beta (5Y) | 0.04 |
52-Week Price Change | -2.67% |
50-Day Moving Average | 14.62 |
200-Day Moving Average | 14.99 |
Relative Strength Index (RSI) | 33.54 |
Average Volume (20 Days) | 14,699 |
Short Selling Information
The latest short interest is 4,030, so 0.10% of the outstanding shares have been sold short.
Short Interest | 4,030 |
Short Previous Month | 4,006 |
Short % of Shares Out | 0.10% |
Short % of Float | 0.11% |
Short Ratio (days to cover) | 0.26 |
Income Statement
In the last 12 months, BAFN had revenue of $78.21 million and earned $7.80 million in profits. Earnings per share was $1.90.
Revenue | 78.21M |
Gross Profit | 78.21M |
Operating Income | 13.85M |
Pretax Income | 7.29M |
Net Income | 7.80M |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | $1.90 |
Full Income Statement Balance Sheet
The company has $78.58 million in cash and $61.49 million in debt, giving a net cash position of $17.09 million or $4.13 per share.
Cash & Cash Equivalents | 78.58M |
Total Debt | 61.49M |
Net Cash | 17.09M |
Net Cash Per Share | $4.13 |
Equity (Book Value) | 108.22M |
Book Value Per Share | 22.37 |
Working Capital | -1.08B |
Full Balance Sheet Margins
Gross Margin | n/a |
Operating Margin | 17.71% |
Pretax Margin | 15.95% |
Profit Margin | 11.94% |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $0.32, which amounts to a dividend yield of 2.58%.
Dividend Per Share | $0.32 |
Dividend Yield | 2.58% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 16.82% |
Buyback Yield | 1.02% |
Shareholder Yield | 3.47% |
Earnings Yield | 14.46% |
FCF Yield | n/a |
Dividend Details Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside | |
Stock Splits
The last stock split was on May 12, 2021. It was a forward split with a ratio of 1.5:1.
Last Split Date | May 12, 2021 |
Split Type | Forward |
Split Ratio | 1.5:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |